Prime Medicine, Inc. (Nasdaq:PRME)
Health Care/Life Sciences • Biotechnology
CIK 1894562
Company
Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.
Address
60 First Street
Cambridge, Massachusetts 02141-2300
60 First Street
Cambridge, Massachusetts 02141-2300
Employees
234
234
Stock Info
Close
$2.3100
$2.3100
Day Range
2.1500 - 2.3250
2.1500 - 2.3250
52 Week Range
2.1200 - 8.5800
2.1200 - 8.5800
Average volume
1.08M
1.08M
Short Interest
18.06M (02/14/25)
18.06M (02/14/25)
% of Float Shorted
34.78%
34.78%
Market Cap
$302.98M
$302.98M
Revenue
N/A
N/A
Net Income
-$198.13M
-$198.13M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
President, Chief Executive Officer & Director Keith M. Gottesdiener |
Director Jeffrey D. Marrazzo |
Independent Director Michael Anthony Kelly |
SEC filings
Date | Form | Event |
---|---|---|
13 Dec, 2024 | S-3 | |
9 Dec, 2024 | 4 | |
9 Dec, 2024 | 4 | |
9 Dec, 2024 | 4 | |
22 Nov, 2024 | SC 13D/A | |
12 Nov, 2024 | SC 13G/A | |
12 Nov, 2024 | 10-Q | |
12 Nov, 2024 | 8-K | |
24 Oct, 2024 | 8-K | |
10 Oct, 2024 | 4 | |
4 Oct, 2024 | SC 13G | |
30 Sep, 2024 | 8-K | |
8 Aug, 2024 | 8-K | |
8 Aug, 2024 | 10-Q | |
14 Jun, 2024 | 4 | |
14 Jun, 2024 | 4 | |
14 Jun, 2024 | 4 | |
14 Jun, 2024 | 4 | |
14 Jun, 2024 | 4 | |
14 Jun, 2024 | 4 | |
14 Jun, 2024 | 4 | |
12 Jun, 2024 | 8-K | |
7 Jun, 2024 | 4 | |
21 May, 2024 | DEFA14A | |
21 May, 2024 | 8-K | |
21 May, 2024 | 4 | |
21 May, 2024 | 4 | |
21 May, 2024 | 4 | |
10 May, 2024 | 10-Q | |
10 May, 2024 | 8-K | |
29 Apr, 2024 | DEFA14A | |
29 Apr, 2024 | DEF 14A | |
29 Apr, 2024 | ARS | |
19 Apr, 2024 | PRE 14A | |
4 Mar, 2024 | 4 | |
1 Mar, 2024 | S-8 | |
1 Mar, 2024 | 10-K | |
1 Mar, 2024 | 8-K | |
29 Feb, 2024 | 3 | |
29 Feb, 2024 | SC 13G/A | |
27 Feb, 2024 | 4 | |
23 Feb, 2024 | 4 | |
23 Feb, 2024 | 4 | |
23 Feb, 2024 | 4 | |
23 Feb, 2024 | 4 | |
23 Feb, 2024 | 4 | |
22 Feb, 2024 | SC 13D | |
20 Feb, 2024 | 4 | |
20 Feb, 2024 | 4 | |
20 Feb, 2024 | 4 | |
16 Feb, 2024 | 8-K | |
16 Feb, 2024 | 424B5 | |
15 Feb, 2024 | FWP | |
14 Feb, 2024 | 424B5 | |
14 Feb, 2024 | 8-K | |
9 Feb, 2024 | SC 13G/A | |
9 Feb, 2024 | SC 13G/A | |
8 Jan, 2024 | 8-K | |
5 Jan, 2024 | 8-K | |
5 Jan, 2024 | 8-K | |
14 Nov, 2023 | 4 | |
13 Nov, 2023 | EFFECT | |
9 Nov, 2023 | CORRESP | |
7 Nov, 2023 | UPLOAD | |
3 Nov, 2023 | 8-K | |
3 Nov, 2023 | 10-Q | |
3 Nov, 2023 | S-3 | |
7 Aug, 2023 | 10-Q | |
7 Aug, 2023 | 8-K | |
26 Jul, 2023 | 4/A | |
25 Jul, 2023 | 4 | |
22 Jun, 2023 | 4 | |
16 Jun, 2023 | 4 | |
16 Jun, 2023 | 8-K | |
16 Jun, 2023 | 4 | |
16 Jun, 2023 | 4 | |
16 Jun, 2023 | 4 | |
16 Jun, 2023 | 4 | |
16 Jun, 2023 | 4 | |
15 Jun, 2023 | 4 | |
13 Jun, 2023 | 4 | |
12 Jun, 2023 | 144 | |
9 Jun, 2023 | 4 | |
7 Jun, 2023 | 4 | |
5 Jun, 2023 | 144 | |
2 Jun, 2023 | 4 | |
31 May, 2023 | 4 | |
30 May, 2023 | 144 | |
26 May, 2023 | 4 | |
24 May, 2023 | 4 | |
22 May, 2023 | 4 | |
18 May, 2023 | 4 | |
18 May, 2023 | 144 | |
17 May, 2023 | 8-K | |
16 May, 2023 | 4 | |
12 May, 2023 | 3 | |
12 May, 2023 | 4 | |
12 May, 2023 | 4 | |
11 May, 2023 | DEFA14A | |
11 May, 2023 | 10-Q | |
11 May, 2023 | 8-K | |
11 May, 2023 | 8-K | |
10 May, 2023 | 4 | |
8 May, 2023 | 144 | |
28 Apr, 2023 | DEFA14A | |
28 Apr, 2023 | ARS | |
28 Apr, 2023 | DEF 14A | |
20 Apr, 2023 | 4 | |
20 Apr, 2023 | 4 | |
4 Apr, 2023 | 4 | |
4 Apr, 2023 | 4 | |
4 Apr, 2023 | 4 | |
4 Apr, 2023 | 4 | |
4 Apr, 2023 | 4 | |
4 Apr, 2023 | 4 | |
10 Mar, 2023 | 8-K/A | |
9 Mar, 2023 | 10-K | |
9 Mar, 2023 | S-8 | |
9 Mar, 2023 | 8-K | |
13 Feb, 2023 | SC 13G | |
10 Feb, 2023 | SC 13G | |
9 Feb, 2023 | SC 13G/A | |
7 Feb, 2023 | SC 13G | |
9 Jan, 2023 | 8-K | |
14 Nov, 2022 | 10-Q | |
26 Oct, 2022 | 4 | |
26 Oct, 2022 | 4 | |
26 Oct, 2022 | 4 | |
26 Oct, 2022 | SC 13G | |
26 Oct, 2022 | 4 | |
26 Oct, 2022 | 4 | |
26 Oct, 2022 | 4 | |
24 Oct, 2022 | 3/A | |
24 Oct, 2022 | 8-K | |
21 Oct, 2022 | 424B4 | IPO completed |
21 Oct, 2022 | 4 | |
21 Oct, 2022 | 4 | |
21 Oct, 2022 | 4 | |
20 Oct, 2022 | FWP | |
19 Oct, 2022 | EFFECT | |
19 Oct, 2022 | 3 | |
19 Oct, 2022 | 3 | |
19 Oct, 2022 | 3 | |
19 Oct, 2022 | 3 | |
19 Oct, 2022 | 3 | |
19 Oct, 2022 | 3 | |
19 Oct, 2022 | 3 | |
19 Oct, 2022 | 3 | |
19 Oct, 2022 | 3 | |
19 Oct, 2022 | 3 | |
19 Oct, 2022 | 3 | |
19 Oct, 2022 | S-8 | |
19 Oct, 2022 | S-1MEF | |
19 Oct, 2022 | CERT | |
19 Oct, 2022 | 3 | |
19 Oct, 2022 | 3 | |
19 Oct, 2022 | 3 | |
19 Oct, 2022 | 3 | |
19 Oct, 2022 | 3 | |
19 Oct, 2022 | SEC STAFF | |
17 Oct, 2022 | FWP | |
17 Oct, 2022 | CORRESP | |
17 Oct, 2022 | S-1/A | |
17 Oct, 2022 | CORRESP | |
17 Oct, 2022 | 8-A12B | |
17 Oct, 2022 | CORRESP | |
14 Oct, 2022 | UPLOAD | |
13 Oct, 2022 | CORRESP | |
13 Oct, 2022 | S-1/A | |
7 Oct, 2022 | CORRESP | |
30 Sep, 2022 | UPLOAD | |
23 Sep, 2022 | S-1 | |
5 Aug, 2022 | DRS/A | |
6 May, 2022 | DRS/A | |
11 Apr, 2022 | SEC STAFF | |
8 Apr, 2022 | DRS/A | |
8 Apr, 2022 | DRSLTR | |
30 Mar, 2022 | UPLOAD | |
25 Mar, 2022 | DRS/A | |
25 Mar, 2022 | DRSLTR | |
15 Mar, 2022 | UPLOAD | |
7 Mar, 2022 | DRS/A | |
7 Mar, 2022 | DRSLTR | |
17 Feb, 2022 | UPLOAD | |
4 Feb, 2022 | DRS/A | |
4 Feb, 2022 | DRSLTR | |
18 Jan, 2022 | UPLOAD | |
12 Jan, 2022 | DRS/A | |
20 Dec, 2021 | DRS |
Last update:2025-03-06 12:40:54.275176
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.